Back
Innovator Gradient Tactical Rotation Strategy ETF Vs. Nutex Health, Inc. Industry Stock Comparison
Sell
41
IGTR
Innovator Gradient Tactical Rotation Strategy ETF
Last Price:
$28.88
Seasonality Move:
1.5%
Sell
41
NUTX
Nutex Health, Inc.
Last Price:
$101.03
Seasonality Move:
-20.28%
Sell
41
Innovator Gradient Tactical Rotation Strategy ETF (IGTR)
is a Sell
Is Innovator Gradient Tactical Rotation Strategy ETF a Buy, Sell or Hold?
-
The current Innovator Gradient Tactical Rotation Strategy ETF [IGTR] share price is $28.66. The Score for IGTR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
IGTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Nutex Health, Inc. (NUTX)
is a Sell
Is Nutex Health, Inc. a Buy, Sell or Hold?
-
The current Nutex Health, Inc. [NUTX] share price is $100.92. The Score for NUTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NUTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGTR Stock Price Chart
What is Innovator Gradient Tactical Rotation Strategy ETF's stock price today?
-
The Innovator Gradient Tactical Rotation Strategy ETF share price today is $28.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NUTX Stock Price Chart
What is Nutex Health, Inc.'s stock price today?
-
The Nutex Health, Inc. share price today is $100.92The current trend is relatively stagnant and NUTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
IGTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.3 | Buy |
| Relative Strength Index (14 RSI): | 50.11 | Buy |
| Chaikin Money Flow: | 6173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.9 - 29.5) | Sell |
| Bollinger Bands (100): | (27.2 - 29.64) | Buy |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.45 | Sell |
| Relative Strength Index (14 RSI): | 50.67 | Buy |
| Chaikin Money Flow: | 149587 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.87 - 105.25) | Buy |
| Bollinger Bands (100): | (98.59 - 163.61) | Sell |
IGTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.13 | Buy |
| 20-day SMA: | 28.41 | Buy |
| 50-day SMA: | 29.23 | Sell |
| 200-day SMA: | 26.94 | Buy |
| 8-day EMA: | 27.78 | Buy |
| 20-day EMA: | 22.54 | Buy |
| 50-day EMA: | 13.35 | Buy |
| 200-day EMA: | 4.18 | Buy |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.73 | Buy |
| 20-day SMA: | 94.26 | Buy |
| 50-day SMA: | 110.15 | Sell |
| 200-day SMA: | 117.56 | Sell |
| 8-day EMA: | 96.63 | Buy |
| 20-day EMA: | 97.75 | Buy |
| 50-day EMA: | 109.29 | Sell |
| 200-day EMA: | 114.05 | Sell |
Innovator Gradient Tactical Rotation Strategy ETF Earnings Growth & IGTR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health, Inc. Earnings Growth & NUTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.99 per share, an increase next quarter of $1.49 per share, an increase this year of $16.22 per share, and an increase next year of $0.74 per share.
Innovator Gradient Tactical Rotation Strategy ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||